On Tuesday, MaxCyte Inc (NASDAQ: MXCT) was -6.37% drop from the session before settling in for the closing price of $3.61. A 52-week range for MXCT has been $3.16 – $5.55.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 20.83%. When this article was written, the company’s average yearly earnings per share was at -11.97%. With a float of $97.34 million, this company’s outstanding shares have now reached $103.96 million.
The extent of productivity of a business whose workforce counts for 143 workers is very important to gauge. In terms of profitability, gross margin is 79.04%, operating margin of -101.56%, and the pretax margin is -78.36%.
MaxCyte Inc (MXCT) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward MaxCyte Inc stocks. The insider ownership of MaxCyte Inc is 7.72%, while institutional ownership is 68.13%. The most recent insider transaction that took place on Nov 01 ’24, was worth 177,403. In this transaction Director of this company sold 47,689 shares at a rate of $3.72, taking the stock ownership to the 269,118 shares. Before that another transaction happened on Oct 28 ’24, when Company’s Director sold 3,000 for $3.72, making the entire transaction worth $11,166. This insider now owns 141,950 shares in total.
MaxCyte Inc (MXCT) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.05 earnings per share (EPS) during the time that was better than consensus figure (set at -0.07) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -11.97% per share during the next fiscal year.
MaxCyte Inc (NASDAQ: MXCT) Trading Performance Indicators
You can see what MaxCyte Inc (MXCT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 9.22. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.34, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.39 in one year’s time.
Technical Analysis of MaxCyte Inc (MXCT)
The latest stats from [MaxCyte Inc, MXCT] show that its last 5-days average volume of 1.1 million was superior to 0.53 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 64.62%. Additionally, its Average True Range was 0.22.
During the past 100 days, MaxCyte Inc’s (MXCT) raw stochastic average was set at 10.91%, which indicates a significant decrease from 25.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 71.36% in the past 14 days, which was higher than the 56.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.71, while its 200-day Moving Average is $4.15. Now, the first resistance to watch is $3.55. This is followed by the second major resistance level at $3.72. The third major resistance level sits at $3.83. If the price goes on to break the first support level at $3.27, it is likely to go to the next support level at $3.16. Assuming the price breaks the second support level, the third support level stands at $2.99.
MaxCyte Inc (NASDAQ: MXCT) Key Stats
There are 105,483K outstanding shares of the company, which has a market capitalization of 356.53 million. As of now, sales total 41,290 K while income totals -37,920 K. Its latest quarter income was 8,160 K while its last quarter net income were -11,560 K.
